136 related articles for article (PubMed ID: 3315284)
1. Repeated high-dose cyclophosphamide administration in bone marrow transplantation: exposure to activated metabolites.
Schuler U; Ehninger G; Wagner T
Cancer Chemother Pharmacol; 1987; 20(3):248-52. PubMed ID: 3315284
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of high-dose cyclophosphamide for bone marrow transplantation.
Fasola G; Lo Greco P; Calori E; Zilli M; Verlicchi F; Motta MR; Ricci P; Baccarani M; Tura S
Haematologica; 1991; 76(2):120-5. PubMed ID: 1937169
[TBL] [Abstract][Full Text] [Related]
3. The effect of busulphan on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite: time interval influence on therapeutic efficacy and therapy-related toxicity.
Hassan M; Ljungman P; Ringdén O; Hassan Z; Oberg G; Nilsson C; Békassy A; Bielenstein M; Abdel-Rehim M; Georén S; Astner L
Bone Marrow Transplant; 2000 May; 25(9):915-24. PubMed ID: 10800057
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and metabolism of cyclophosphamide administered after total body irradiation of bone marrow transplant recipients.
Schuler U; Waidelich P; Kolb H; Wagner T; Ehninger G
Eur J Clin Pharmacol; 1991; 40(5):521-3. PubMed ID: 1884728
[TBL] [Abstract][Full Text] [Related]
5. Urinary excretion and pharmacokinetics of acrolein and its parent drug cyclophosphamide in bone marrow transplant patients.
Al-Rawithi S; El-Yazigi A; Ernst P; Al-Fiar F; Nicholls PJ
Bone Marrow Transplant; 1998 Sep; 22(5):485-90. PubMed ID: 9733272
[TBL] [Abstract][Full Text] [Related]
6. Conditioning with cyclophosphamide/antithymocyte globulin for allogeneic bone marrow transplantation from HLA-matched siblings in children with severe aplastic anemia.
Azuma E; Kojima S; Kato K; Matsuyama T; Yamada Y; Kondo N; Sawada H; Hanada M; Shibata T; Tabata N; Watanabe M; Shimono Y; Deguchi T; Umemoto M; Higashikawa M; Kawasaki H; Komada Y; Sakurai M
Bone Marrow Transplant; 1997 Jun; 19(11):1085-7. PubMed ID: 9193750
[TBL] [Abstract][Full Text] [Related]
7. PLasma half-life and urinary excretion of cyclophosphamide in children.
Sladek NE; Priest J; Doeden D; Mirocha CJ; Pathre S; Krivit W
Cancer Treat Rep; 1980; 64(10-11):1061-6. PubMed ID: 7459891
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow transplantation in 65 patients with severe aplastic anemia.
Gluckman E; Devergie A; Gerotta I; Hors J; Sasportes M; Boiron M; Bernard J
Bull Cancer; 1981; 68(1):74-7. PubMed ID: 7013871
[TBL] [Abstract][Full Text] [Related]
9. [Cyclophosphamide and total lymph node irradiation as conditioning for bone marrow transplant in severe aplastic anemia].
Sotti G; Rigon A; Polico C; Scarzello G; Friso ML; Calzavara F; Fabbris R; Cauzzo C
Radiol Med; 1987 Jun; 73(6):545-6. PubMed ID: 3299513
[TBL] [Abstract][Full Text] [Related]
10. Normal neurodevelopment in four young children treated with bone marrow transplantation for acute leukemia or aplastic anemia.
Kaleita TA; Shields WD; Tesler A; Feig SA
Pediatrics; 1989 May; 83(5):753-7. PubMed ID: 2654868
[TBL] [Abstract][Full Text] [Related]
11. Cytosine arabinoside, cyclophosphamide and total body irradiation conditioning regimens for bone marrow transplantation.
Mwangemi PM; Higby D
East Afr Med J; 1985 May; 62(5):309-14. PubMed ID: 3899599
[No Abstract] [Full Text] [Related]
12. Unrelated donor bone marrow transplants for severe aplastic anemia with conditioning using total body irradiation and cyclophosphamide.
Kim SY; Lee JW; Lim J; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Kim CC
Biol Blood Marrow Transplant; 2007 Jul; 13(7):863-70. PubMed ID: 17580265
[TBL] [Abstract][Full Text] [Related]
13. Results of transplanting bone marrow from genetically identical twins into patients with aplastic anemia.
Hinterberger W; Rowlings PA; Hinterberger-Fischer M; Gibson J; Jacobsen N; Klein JP; Kolb HJ; Stevens DA; Horowitz MM; Gale RP
Ann Intern Med; 1997 Jan; 126(2):116-22. PubMed ID: 9005745
[TBL] [Abstract][Full Text] [Related]
14. Transient engraftment of syngeneic bone marrow after conditioning with high-dose cyclophosphamide and thoracoabdominal irradiation in a patient with aplastic anemia.
Matsue K; Niki T; Shiobara S; Ueda M; Ohtake S; Mori T; Matsuda T; Harada M
Am J Hematol; 1990 Jan; 33(1):56-60. PubMed ID: 2293762
[TBL] [Abstract][Full Text] [Related]
15. [Whole-body irradiation for bone marrow transplantation].
Di Pietrantonj F; Proietti A; Capirci C
Radiol Med; 1984 Jun; 70(6):396-410. PubMed ID: 6398469
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and metabolism of cyclophosphamide in paediatric patients.
Tasso MJ; Boddy AV; Price L; Wyllie RA; Pearson AD; Idle JR
Cancer Chemother Pharmacol; 1992; 30(3):207-11. PubMed ID: 1628369
[TBL] [Abstract][Full Text] [Related]
17. Thyroid dysfunction among long-term survivors of bone marrow transplantation.
Sklar CA; Kim TH; Ramsay NK
Am J Med; 1982 Nov; 73(5):688-94. PubMed ID: 6753576
[TBL] [Abstract][Full Text] [Related]
18. Plasma concentrations of 4-hydroxycyclophosphamide and phosphoramide mustard in patients repeatedly given high doses of cyclophosphamide in preparation for bone marrow transplantation.
Sladek NE; Doeden D; Powers JF; Krivit W
Cancer Treat Rep; 1984 Oct; 68(10):1247-54. PubMed ID: 6395951
[TBL] [Abstract][Full Text] [Related]
19. Fractionated administration of high-dose cyclophosphamide: influence on dose-dependent changes in pharmacokinetics and metabolism.
Busse D; Busch FW; Schweizer E; Bohnenstengel F; Eichelbaum M; Fischer P; Schumacher K; Aulitzky WE; Kroemer HK
Cancer Chemother Pharmacol; 1999; 43(3):263-8. PubMed ID: 9923558
[TBL] [Abstract][Full Text] [Related]
20. [Bone marrow transplantation in severe aplastic anemia and acute leukemia].
Speck B; Sartorius J; Cornu P; Nissen C; Weber W; Gratwohl A
Onkologie; 1979 Apr; 2(2):79-82. PubMed ID: 42865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
